Evidence map›Paper›PMID 37273676›Full record

ArticleClinical case reports2023

Acute vision loss due to CML leukemic retinopathy reversed with leukapheresis.

Sally Leong, Tiffanie Do, Michael Shodiya, Jennifer Lee

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical case reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Sally LeongDivision of Hematology and Medical Oncology, Department of Medicine Harbor-UCLA Medical Center Torrance California USA.ORCID https://orcid.org/0000-0001-8689-4882
Tiffanie DoDivision of Hematology and Medical Oncology, Department of Medicine Harbor-UCLA Medical Center Torrance California USA.
Michael ShodiyaDivision of Hematology and Medical Oncology, Department of Medicine UCLA Ronald Reagan Medical Center Los Angeles California USA.
Jennifer LeeDivision of Hematology and Medical Oncology, Department of Medicine Harbor-UCLA Medical Center Torrance California USA.ORCID https://orcid.org/0000-0002-9056-9449
UCLA Medical Center · USRonald Reagan UCLA Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Leukemic retinopathy is a severe complication of severe leukocytosis that results from untreated chronic myelogenous leukemia (CML). Immediate cytoreduction via leukapheresis may reverse ocular manifestations and prevent permanent vision damage. We present a case of a patient with acute unilateral vision loss found to have leukemic retinopathy in the setting of untreated CML with improvement of visual symptoms after leukapheresis and initiation of hydroxyurea.

Indexed as

central retinal vein occlusionchronic myeloid leukemiacytoreductionleukapheresisretinopathy

Identifiers

PMID37273676
PMCPMC10238709
OpenAlexW4379260729

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.